T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion

被引:92
|
作者
Hindley, James P. [1 ]
Jones, Emma [1 ]
Smart, Kathryn [1 ]
Bridgeman, Hayley [1 ]
Lauder, Sarah N. [1 ]
Ondondo, Beatrice [1 ]
Cutting, Scott [1 ]
Ladell, Kristin [1 ]
Wynn, Katherine K. [1 ]
Withers, David [2 ]
Price, David A. [1 ]
Ager, Ann [1 ]
Godkin, Andrew J. [1 ]
Gallimore, Awen M. [1 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff CF 144XN, S Glam, Wales
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, MRC Ctr Immune Regulat, Birmingham, W Midlands, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
LYMPHOID ORGAN DEVELOPMENT; ESTABLISHED MELANOMA; LYMPHOTOXIN-ALPHA; TISSUE; MICE; INFLAMMATION; IMMUNITY; CANCER; NODES; SULFOTRANSFERASE;
D O I
10.1158/0008-5472.CAN-12-1912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The evolution of immune blockades in tumors limits successful antitumor immunity, but the mechanisms underlying this process are not fully understood. Depletion of regulatory T cells (Treg), a T-cell subset that dampens excessive inflammatory and autoreactive responses, can allow activation of tumor-specific T cells. However, cancer immunotherapy studies have shown that a persistent failure of activated lymphocytes to infiltrate tumors remains a fundamental problem. In evaluating this issue, we found that despite an increase in T-cell activation and proliferation following Treg depletion, there was no significant association with tumor growth rate. In contrast, there was a highly significant association between low tumor growth rate and the extent of T-cell infiltration. Further analyses revealed a total concordance between low tumor growth rate, high T-cell infiltration, and the presence of high endothelial venules (HEV). HEV are blood vessels normally found in secondary lymphoid tissue where they are specialized for lymphocyte recruitment. Thus, our findings suggest that Treg depletion may promote HEV neogenesis, facilitating increased lymphocyte infiltration and destruction of the tumor tissue. These findings are important as they point to a hitherto unidentified role of Tregs, the manipulation of which may refine strategies for more effective cancer immunotherapy. Cancer Res; 72(21); 5473-82. (C)2012 AACR.
引用
收藏
页码:5473 / 5482
页数:10
相关论文
共 50 条
  • [41] Simultaneous blockade of several endothelial ligands is required to prevent alloreactive T-cell trafficking to target tissues
    Beilhack, A.
    Baker, J.
    Riedel, S.
    Brede, C.
    Baeuerlein, C. A.
    Jordan-Garrote, A. L.
    Kiesel, C.
    Monteforte, R.
    Ritz, M.
    Mattenheimer, K.
    Grether, M.
    Beilhack, G. F.
    Einsele, H.
    Negrin, R. S.
    Schulz, S.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S15 - S15
  • [42] IDENTIFICATION OF T-CELL LYMPHOMA TUMOR ANTIGENS ON HUMAN T-CELL LINES
    KAPLAN, J
    TILTON, J
    PETERSON, WD
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 1035 - 1035
  • [43] A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy
    Canavan, James B.
    Afzali, Behdad
    Scotta, Cristiano
    Fazekasova, Henrieta
    Edozie, Francis C.
    Macdonald, Thomas T.
    Hernandez-Fuentes, Maria P.
    Lombardi, Giovanna
    Lord, Graham M.
    BLOOD, 2012, 119 (08) : E57 - E66
  • [44] Effects of interferon-α on regulatory T-cell depletion in cancer immunotherapy
    Wall, Shaming
    Jeansonne, Duane
    Lin, Pei-Yi
    Liu, Aijie
    Rennebeck, Gaby
    Thibodeaux, Suzanne
    Livi, Carolina
    Daniel, Ben
    Curiel, Tyler
    CYTOKINE, 2008, 43 (03) : 324 - 324
  • [45] Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
    Teng, Michele W. L.
    Swann, Jeremy B.
    von Scheidt, Bianca
    Sharkey, Janelle
    Zerafa, Nadeen
    McLaughlin, Nicole
    Yamaguchi, Tomoyuki
    Sakaguchi, Shimon
    Darcy, Phillip K.
    Smyth, Mark J.
    CANCER RESEARCH, 2010, 70 (07) : 2665 - 2674
  • [46] Tumor Cell Repopulation between Cycles of Chemotherapy is Inhibited by Regulatory T-Cell Depletion in a Murine Mesothelioma Model
    Wu, Licun
    Yun, Zhihong
    Tagawa, Tetsuzo
    Rey-McIntyre, Katrina
    Anraku, Masaki
    de Perrot, Marc
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1578 - 1586
  • [47] Control of T-cell development by the Pre-T and alpha beta T-cell
    vonBoehmer, H
    RECEPTOR ACTIVATION BY ANTIGENS, CYTOKINES, HORMONES, AND GROWTH FACTORS, 1995, 766 : 52 - 61
  • [48] T-cell therapies for T-cell lymphoma
    Toner, Keri
    Bollard, Catherine M.
    Dave, Hema
    CYTOTHERAPY, 2019, 21 (09) : 935 - 942
  • [49] Psoriasis and HIV: A T-cell mediated skin disorder occurring in the setting of T-cell depletion
    Donoghue, S. E.
    Vekic, D. A.
    Whitfeld, M. J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 : 35 - 36
  • [50] T-CELL REGULATION OF T-CELL FUNCTION
    LEE, SC
    LUCAS, ZJ
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 1030 - 1030